| Rebecca Darlene Maintz, RPH | |
|
110 S Oak St, Advance, MO 63730-8343 | |
| (573) 722-3562 | |
| (573) 722-3569 |
| Full Name | Rebecca Darlene Maintz |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 110 S Oak St, Advance, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861185878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 043653 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca Darlene Maintz, RPH 110 S Oak St, Advance, MO 63730-8343 Ph: (573) 722-3562 | Rebecca Darlene Maintz, RPH 110 S Oak St, Advance, MO 63730-8343 Ph: (573) 722-3562 |
News Archive
American-Indian adolescents continue to have the highest rates of illicit drug use among all ethnic groups. Although previous research has found that increasing adolescent exposure to protective factors can reduce their risk for substance abuse, this has not been thoroughly examined in American-Indian adolescents. Recent findings from a University of Missouri study reveal that positive family relationships and religious affiliation can counteract risk factors - including addicted family members, exposure to violence and deviant peers - associated with drug use.
A protein associated with conditions of metabolic imbalance, such as diabetes and obesity, may play a role in the development of aggressive forms of breast cancer, according to new findings by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and their colleagues.
With the flu and common colds going around, it's hard enough already to stay healthy during the winter, but a rodent infestation could mean a host of other potential health concerns. Rodents can contaminate food sources with feces that can spread Salmonella and Hantavirus. With rodents invading an estimated 21 million homes every winter, the threat to consumers is very real.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
An experimental drug for a rare, inherited form of amyotrophic lateral sclerosis (ALS) has shown promise in a phase 1/phase 2 clinical trial conducted at Washington University School of Medicine in St. Louis, Massachusetts General Hospital in Boston and other sites around the world and sponsored by the pharmaceutical company Biogen Inc.
› Verified 5 days ago
Sarah Dovin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 S Oak St, Advance, MO 63730 Phone: 573-722-3562 | |
Bruce J Dovin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 S Oak St, Advance, MO 63730 Phone: 573-722-3562 | |
Jodi Crader, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 Osage Dr, Advance, MO 63730 Phone: 573-270-5121 |